AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Mugglehead

Published November 4, 2026

Rapport Therapeutics reports US$815.4M liquidity and runway through 2029 - Mugglehead

Read the full story at Mugglehead

Psychedelics . NASDAQ: CMPS. Compass Pathways reports US$444M cash and ... All Psychedelics . Cannabis. All CannabisCBDPolicyEdiblesHemp. Company.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics